P2RY12 and COVID-19: Therefore, we conducted a systematic review and meta-analysis following the PICO framework to investigate on the effects of antiplatelet treatments, such as aspirin, clopidogrel, and P2Y12 inhibitors, on patients diagnosed with COVID-19.